Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MKS Instruments ( (MKSI) ) has provided an update.
On January 24, 2025, MKS Instruments announced the successful repricing of its $2.5 billion USD and €596 million EUR secured tranche B term loans maturing in 2029, resulting in reduced interest rates and a voluntary prepayment of $100 million, lowering the USD tranche B principal to $2.5 billion. This repricing is expected to generate approximately $15 million in annualized cash interest savings, indicating the company’s ongoing efforts to deleverage its balance sheet and enhance free cash flow. The move underscores MKS Instruments’ strategic initiatives to cut costs and optimize financial operations, enhancing its market positioning and stakeholder value.
More about MKS Instruments
MKS Instruments is a global provider of enabling technologies that transform industries such as semiconductor manufacturing, electronics, packaging, and specialty industrial applications. The company offers foundational technology solutions including instruments, subsystems, systems, process control solutions, and specialty chemicals technology aimed at improving process performance and productivity while addressing miniaturization and complexity challenges in advanced device manufacturing.
YTD Price Performance: 12.88%
Average Trading Volume: 800,216
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $8.05B
For detailed information about MKSI stock, go to TipRanks’ Stock Analysis page.
